Humira becomes Britain’s first biotech blockbuster

January 26, 2006
Research and Development

The UK biotech company which discovered rheumatoid arthritis drug Humira has hailed its success after sales passed the $1 billion …

Eisai invests

January 26, 2006
Manufacturing and Production

Japanese pharma company Eisai is to open a major new single site facility in the UK, marking the country out …

Amgen to expand R&D investment in UK

January 26, 2006
Research and Development

Amgen, the world's largest biotechnology company is to open a new drug development centre in Uxbridge, London, as part of …

Helping marketers to break ranks

January 26, 2006
Business Services

In the pharma industry personnel development seems to be viewed from a short-term perspective. Where personnel development is undertaken, process …

Limited access to Alzheimer’s drugs leaves patients groups dissatisfied

January 25, 2006
Sales and Marketing

Patient groups have expressed disappointment at NICE plans to allow only some patients with Alzheimer's disease to have drug treatment, …

Roche and biotech swap roles in novel collaboration

January 24, 2006
Research and Development

Roche and Amira Pharmaceuticals have entered into a new and unorthodox drug discovery and development partnership which will see them …

Mergers will create gulf between GPs and PCTs

January 20, 2006

Health service leaders have warned that planned mergers of Primary Care Trusts in England will create larger bodies more remote …

Wyeth submits follow-up to antidepressant blockbuster

January 20, 2006
Sales and Marketing

Wyeth has submitted its new antidepressant desvenlafaxine to the FDA, a drug it hopes will be a successor to its …

Next generation hypertension drug ready for 2006 filing

January 20, 2006
Sales and Marketing

Next generation hypertension drug aliskiren is on track for filing in late 2006 and is showing promising results in the …

Campaign to raise awareness of pharma code of conduct

January 20, 2006
Medical Communications

The UK pharmaceutical industry's newly re-drafted code of conduct is to benefit from a PR campaign to promote awareness of …

Next generation monoclonal antibodies to enter clinical trials in 2007

January 20, 2006
Research and Development Ablynx, Novartis

Novartis has signed a deal with Belgium biotech Ablynx to develop the next generation of monoclonal antibodies with clinical development …

FDA looks to streamline early research

January 19, 2006
Research and Development

The FDA has unveiled plans to allow more small-scale exploratory studies of drugs in humans before formal phase I studies …

Novartis to appeal Zelnorm rejection

January 18, 2006
Sales and Marketing

Novartis says it will appeal against an EMEA decision not to recommend its irritable bowel syndrome drug Zelnorm. Zelnorm (tegaserod) …

Prescribers ready to defy NICE in Alzheimer’s drug row

January 18, 2006
Sales and Marketing

Patient groups and manufacturers are hoping NICE will reverse its decision to deny access to Alzheimer's drugs on the NHS, …

First-in-class indication expected for Remicade

January 18, 2006
Sales and Marketing

Schering-Plough expects its arthritis treatment Remicade to receive European approval to treat ulcerative colitis in early 2006.If approved Remicade (infliximab) …

StayinFront wins Roche regional contract

January 18, 2006
Business Services

Roche will equip its Central and Eastern European salesforces with StayinFront customer relationship management software after expanding its current contract …

Patient-led NHS revolution to continue, says under fire Hewitt

January 18, 2006

Patricia Hewitt has pledged to press ahead with the next phase of Labour's NHS reforms, despite renewed opposition from within …

Merck in race to bring first cervical cancer vaccine to market

January 18, 2006
Sales and Marketing

Merck and GlaxoSmithKline are head-to-head in a race to establish a market for their rival cervical cancer vaccines, both set …

Drinking straw a novel antibiotic delivery for children

January 17, 2006
Sales and Marketing

A new drinking straw that administers antibiotics to children as they drink has been launched by German pharma company Grunenthal.Clarosip …

Virgo Health wins Cymbalta account

January 17, 2006
Medical Communications

Virgo Health has been appointed to promote depression brand Cymbalta to healthcare professionals in the UK following a two-way competitive …

The Gateway to Local Adoption Series

Latest content